共 333 条
[1]
Olivieri NF(1997)Iron-chelating therapy and the treatment of thalassemia Blood 89 739-61
[2]
Brittenham GM(1997)A risk-benefit assessment of iron-chelation therapy Drug Saf 17 407-21
[3]
Porter JB(1997)Iron chelation therapy J Intern Med 740 37-41
[4]
Hoffbrand AV(1996)Results of long-term iron-chelating therapy Acta Haematol 95 26-36
[5]
Wonke B(1995)Management of thalassemias: growth and development, hormone substitution, vitamin supplementation, and vaccination Semin Hematol 32 269-79
[6]
Gabutti V(1995)Chelation therapy in β-thalassemia: the benefits and limitations of desferrioxamine Semin Hematol 32 304-12
[7]
Piga A(1987)Iron state and hepatic disease in patients with thalassaemia major, treated with long term subcutaneous desferrioxamine J Clin Pathol 40 1353-9
[8]
Kattamis CA(1989)The toxic effects of desferrioxamine Baillieres Clin Haematol 2 459-74
[9]
Kattamis AC(1996)Oral iron chelation Semin Hematol 33 1-8
[10]
Giardina PJ(1992)Aluminium removal: short- and long-term preliminary results with L1 in rats Drugs Today 28 177-82